Programmable RNA demethylation re-sensitizes bladder cancer to cisplatin
Cisplatin-based chemotherapy remains a cornerstone of treatment for advanced bladder cancer, yet resistance to this platinum drug severely limits its ...
Cisplatin-based chemotherapy remains a cornerstone of treatment for advanced bladder cancer, yet resistance to this platinum drug severely limits its ...
New research shows that blocking the CXCL12/CXCR4 signaling axis in ovarian cancer cells produces a paradoxical biphasic response, with moderate ...
Trans-vaccenic acid, an 18-carbon omega-7 trans fatty acid found naturally in beef, lamb, and dairy fat, has long been overshadowed ...
A new study of microbial RNA in the blood of leukemia patients suggests that the circulating metatranscriptome may carry information ...
A multi-omics study shows probiotic-derived metabolites suppress colorectal cancer cell growth, trigger apoptosis, and restore gut microbial balance, supporting their ...
In a small but technically careful study from Lima, Peru, researchers report that two microRNAs circulating in blood plasma, miR-486-3p ...
A survey of 384 Sudanese cancer patients reveals that war has blocked treatment access for nearly 70 percent, interrupted therapy ...
A new review finds that cognitive behavioral therapy, mindfulness, yoga, and physical activity consistently relieve chronic fatigue across stroke, cancer, ...
A new systematic review and meta-analysis of 20 studies finds that 61 percent of cancer patients resume some anticancer treatment ...
Bladder cancer is the tenth most common malignancy worldwide, with roughly 573,000 new cases and 212,500 deaths recorded in 2020. ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine